| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9600979 | Clinical Oncology | 2005 | 7 Pages |
Abstract
These results highlight the need for additional treatment options for this disease. Similar, if not superior, response rates have already been observed in initial clinical studies of novel, targeted anti-cancer agents.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
X. León, R. Hitt, M. Constenla, A. Rocca, R. Stupp, A.F. Kovács, N. Amellal, E.H. Bessa, J. Bourhis,